PTHS
Pelthos Therapeutics Inc.stockNYSEAMERICAN
Market OpenNov 19, 2026 10:35:24 AM EST
7.41USD+8.811%(+0.60)59,550
PTHS Financials
In Q3 FY 2026 (ended ), Pelthos Therapeutics Inc. (PTHS) reported revenue of $15.4M, net income of −$7.9M, operating cash flow of −$5.16M, and assets of $128.82M (filed ).
Loading financial statements…